These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 24073856

  • 1. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset.
    Kucerova L, Feketeova L, Kozovska Z, Poturnajova M, Matuskova M, Nencka R, Babal P.
    Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856
    [Abstract] [Full Text] [Related]

  • 2. Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity.
    Zhu W, Hai T, Ye L, Cote GJ.
    J Clin Endocrinol Metab; 2010 Jan; 95(1):439-44. PubMed ID: 19897677
    [Abstract] [Full Text] [Related]

  • 3. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP, Liu Y, Zhong W, Yu D, Wen LJ, Jin CS.
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [Abstract] [Full Text] [Related]

  • 4. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.
    Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD, Sethi T.
    Cancer Res; 2014 Mar 01; 74(5):1554-65. PubMed ID: 24436149
    [Abstract] [Full Text] [Related]

  • 5. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH, Liu AG, Gu WG, Deng L, Cheng XG, Tong TJ, Zhang HZ.
    Oncol Rep; 2013 Aug 01; 30(2):815-23. PubMed ID: 23708735
    [Abstract] [Full Text] [Related]

  • 6. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.
    Banerjee S, Nomura A, Sangwan V, Chugh R, Dudeja V, Vickers SM, Saluja A.
    Clin Cancer Res; 2014 May 01; 20(9):2388-99. PubMed ID: 24634377
    [Abstract] [Full Text] [Related]

  • 7. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
    Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, Pizzolanti G, Galluzzo A, Giordano C.
    PLoS One; 2008 May 01; 3(10):e3544. PubMed ID: 18958156
    [Abstract] [Full Text] [Related]

  • 8. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW, Chang YL, Hsu HS, Lan YT, Chen KH, Chi CW, Chiou SH, Yang DM, Lee CH.
    J Pharmacol Exp Ther; 2012 May 01; 341(2):410-23. PubMed ID: 22328572
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK.
    Oncogene; 2009 Jan 15; 28(2):209-18. PubMed ID: 18836486
    [Abstract] [Full Text] [Related]

  • 10. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma.
    Yu D, Liu Y, Yang J, Jin C, Zhao X, Cheng J, Liu X, Qi X.
    Cell Biochem Biophys; 2015 Jan 15; 71(1):261-9. PubMed ID: 25241082
    [Abstract] [Full Text] [Related]

  • 11. Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
    Huang R, Wang G, Song Y, Tang Q, You Q, Liu Z, Chen Y, Zhang Q, Li J, Muhammand S, Wang X.
    Mol Med Rep; 2015 Aug 15; 12(2):2417-24. PubMed ID: 25936357
    [Abstract] [Full Text] [Related]

  • 12. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.
    Proc Natl Acad Sci U S A; 2009 Sep 22; 106(38):16281-6. PubMed ID: 19805294
    [Abstract] [Full Text] [Related]

  • 13. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A, Feng B, Gu W, Cheng X, Tong T, Zhang H, Hu Y.
    Int J Oncol; 2013 Apr 22; 42(4):1399-407. PubMed ID: 23416969
    [Abstract] [Full Text] [Related]

  • 14. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A, Lu C.
    Cancer Invest; 2008 Jun 22; 26(5):535-42. PubMed ID: 18568776
    [Abstract] [Full Text] [Related]

  • 15. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B, Jimi S, Kondo T, Naganuma Y, Matsumoto T, Kuroki M, Iwasaki H, Emoto M.
    Stem Cells; 2011 Oct 22; 29(10):1485-95. PubMed ID: 21919130
    [Abstract] [Full Text] [Related]

  • 16. CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling.
    Hongo K, Tanaka J, Tsuno NH, Kawai K, Nishikawa T, Shuno Y, Sasaki K, Kaneko M, Hiyoshi M, Sunami E, Kitayama J, Takahashi K, Nagawa H.
    J Surg Res; 2012 Jun 15; 175(2):278-88. PubMed ID: 21601882
    [Abstract] [Full Text] [Related]

  • 17. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY, Schwartz BE, Hsu MY.
    Cancer Res; 2012 Oct 01; 72(19):5111-8. PubMed ID: 22865455
    [Abstract] [Full Text] [Related]

  • 18. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R.
    Stem Cells; 2009 Dec 01; 27(12):2875-83. PubMed ID: 19816957
    [Abstract] [Full Text] [Related]

  • 19. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T, Takigawa N, Osawa M, Harada D, Ninomiya T, Ochi N, Ichihara E, Yamane H, Tanimoto M, Kiura K.
    Cancer Sci; 2013 Jan 01; 104(1):78-84. PubMed ID: 23066953
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.
    Gallmeier E, Hermann PC, Mueller MT, Machado JG, Ziesch A, De Toni EN, Palagyi A, Eisen C, Ellwart JW, Rivera J, Rubio-Viqueira B, Hidalgo M, Bunz F, Göke B, Heeschen C.
    Stem Cells; 2011 Mar 01; 29(3):418-29. PubMed ID: 21308861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.